Garadacimab for hereditary angioedema prophylaxis: Efficacy and safety from a Phase 2 open-label extension trial

被引：0

作者：

Craig, T. J. ^{[1
]}

Reshef, A. ^{[2
]}

Lumry, W. R. ^{[3
]}

Saguer, I. Martinez ^{[4
]}

Jacobs, J. S. ^{[5
]}

Yang, W. H. ^{[6
]}

Aygoren-Pursun, E. ^{[7
]}

Keith, P. K. ^{[8
]}

Busse, P. ^{[9
]}

Magerl, M. ^{[10
]}

Feuersenger, H. ^{[11
]}

Bica, M. A. ^{[11
]}

Glassman, F. ^{[12
]}

Pragst, I. ^{[11
]}

Levy, D. S. ^{[13
]}

机构：

[1] Penn State Univ, Dept Med & Pediat, Allergy Asthma & Immunol, Hershey, PA USA

[2] Barzilai Univ Hosp, Allergy & Immunol Angioedema Ctr, Ashqelon, Israel

[3] AARA Res Ctr, Dallas, TX USA

[4] HZRM Haemophilia Ctr Rhein Main, Morfelden Walldorf, Germany

[5] Allergy & Asthma Clin Res, Walnut Creek, CA USA

[6] Univ Ottawa, Ottawa Allergy Res Corp, Dept Med, Ottawa, ON, Canada

[7] Klinikum Johann Wolfgang Goethe Univ, Klin Kinder & Jugendmed, Frankfurt, Germany

[8] McMaster Univ, Med Ctr Site, Hamilton, ON, Canada

[9] Mt Sinai, New York, NY USA

[10] Charite Univ Med Berlin, Inst Allergol, Fraunhofer Inst Translat Med & Pharmacol ITMP All, Berlin, Germany

[11] CSL Behring Innovat GmbH, Marburg, Germany

[12] CSL Behring, King Of Prussia, PA USA

[13] Univ Calif Irvine, Div Allergy & Immunol, Irvine, CA USA

来源：

ALLERGOLOGIE | 2023年 / 46卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

P8.10

引用

页码：560 / 561

页数：2

共 50 条

[41] Phase 2 Open-Label Extension Study With Donidalorsen in Patients With Hereditary Angioedema: Updated Interim Analysis With Quality-of-Life Data
Bordone, Laura
Newman, Kenneth
Lui, Cindy
Alexander, Veronica
Riedl, Marc
Schneider, Eugene
Cohn, Danny
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB129 - AB129
[42] Adalimumab for nail psoriasis: Efficacy and safety from the open-label extension of a phase-3, randomized, placebo-controlled trial
Gottlieb, Alice B.
Elewski, Boni E.
Okun, Martin M.
Bagel, Jerry
Poulin, Yves
Gu, Yihua
Williams, David A.
Valdecantos, Wendell C.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB33 - AB33
[43] Efficacy and Safety of Switching from Adalimumab to Sarilumab in an Open-label Extension of a Phase 3 Monotherapy Trial in Patients with Active Rheumatoid Arthritis
Burmester, Gerd
Fiore, Stefano
Hu, Chih-Chi
Fay, Jonathan
Lee, Eun-Bong
Genovese, Mark
JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1035 - 1035
[44] Efficacy and Safety of Switching from Adalimumab to Sarilumab in an Open-Label Extension of a Phase 3 Monotherapy Trial in Patients with Active Rheumatoid Arthritis
Burmester, Gerd R.
Fiore, Stefano
Hu, Chih-Chi
Fay, Jonathan
Lee, Eun Bong
Genovese, Mark C.
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[45] Telotristat Ethyl in Carcinoid Syndrome: Safety and Efficacy Results of an Open-Label Extension of the TELECAST Phase 3 Clinical Trial
Pavel, Marianne
Benavent, Marta
Perros, Petros
Srirajaskanthan, Raj
Warner, Richard R. P.
Kulke, Matthew H.
Anthony, Lowell B.
Kunz, Pamela L.
Hoersch, Dieter
Lapuerta, Pablo
Fleming, Rosanna
Gross, David J.
PANCREAS, 2018, 47 (03) : 350 - 350
[46] Telotristat Ethyl in Carcinoid Syndrome: Safety and Efficacy Results of an Open-Label Extension of the TELECAST Phase 3 Clinical Trial
Pavel, M.
Benavent, M.
Perros, P.
Srirajaskanthan, R.
Warner, R. R. P.
Kulke, M. H.
Anthony, L. B.
Kunz, P.
Hoersch, D.
Lapuerta, P.
Fleming, R.
Gross, D.
NEUROENDOCRINOLOGY, 2017, 105 : 205 - 205
[47] Safety and Efficacy of Natalizumab in Japanese Patients with Relapsing-Remitting Multiple Sclerosis: Open-Label Extension Study of a Phase 2 Trial
Saida T.
Kira J.-I.
Kishida S.
Yamamura T.
Ohtsuka N.
Ling Y.
Torii S.
Lucas N.
Kuesters G.
Steiner D.
Tibung J.T.
Neurology and Therapy, 2017, 6 (1) : 39 - 55
[48] Safety and Efficacy of Lenabasum in an Open-Label Extension of a Phase 2 Study in Diffuse Cutaneous Systemic Sclerosis Subjects
Spiera, Robert F.
Hummers, Laura K.
Chung, Lorinda
Frech, Tracy M.
Domsic, Robyn T.
Hsu, Vivien
Furst, Daniel E.
Gordon, Jessica K.
Mayes, Maureen D.
Simms, Robert W.
Lee, Elizabeth
Constantine, Scott
White, Barbara
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[49] Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study
Gleich, Gerald J.
Roufosse, Florence
Chupp, Geoffrey
Faguer, Stanislas
Walz, Bastian
Reiter, Andreas
Yancey, Steven W.
Bentley, Jane H.
Steinfeld, Jonathan
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (12): : 4431 - +
[50] MAINTENANCE OF EFFICACY, SAFETY AND TOLERABILITY OF ARMODAFINIL: AN OPEN-LABEL EXTENSION STUDY
Black, J.
Hull, S. G.
Tiller, J.
Yang, R.
Harsh, J. R.
SLEEP, 2009, 32 : A139 - A139

← 1 2 3 4 5 →